- Product NDC
- 66096-722
- 11-digit product format
- 660960722
- Labeler code
- 66096
- Product ID
- 66096-722_d44b40e1-a611-4469-e053-2a95a90aa702
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Alumen, Calcarea carbonica, DNA, Ferrum phosphoricum, Hepar sulphuris calcareum, Kali carbonicum, Kali muriaticum, Kali sulphuricum, Magnesia phosphorica, Natrum muriaticum, Natrum phosphoricum, RNA, Silicea.
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- OHM PHARMA INC.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2017-11-20
- Substance
- CALCIUM SULFIDE; FERROSOFERRIC PHOSPHATE; HERRING SPERM DNA; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM ALUM; POTASSIUM CARBONATE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SACCHAROMYCES CEREVISIAE RNA; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
- Active strength
- 6; 6; 4; 6; 6; 12; 6; 6; 6; 4; 12; 6; 6 [hp_X]/59mL; [hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL
- Pharmacologic classes
- Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes